Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06305767
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-03-05
Brief Title:
A Clinical Study of V940 Treatment and Pembrolizumab in People With Bladder Cancer V940-005INTerpath-005
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC